Zee Entertainment Enterprises will replace United Spirits in the 50-share CNX Nifty index from 19 September 2014.
Reliance Industries (RIL) annnounced that the Shale Gas industry, in North America has grown exponentially in the past 5 years. As a result Ethane has become the dominant feedstock for crackers replacing liquids. Reliance's investments in Shale Gas and its existing crackers portfolio in India are a natural fit for sourcing Ethane from North America and shipping it to India to attain long term feedstock competitiveness.
RIL is implementing a project to source 1.5 MMTPA of Ethane from US to feed its crackers in India. RIL has now executed storage and capacity agreements for liquefaction and export of ethane with a North American Terminal, which is expected to commence operations in the second half of 2016, the company said in a statement.
For the purpose of transporting liquefied ethane to India in a safe and cost efficient manner, RIL has ordered six state-of-the-art Very Large Ethane Carriers (VLECs) which will be the largest vessels ever built in the world. The ships are expected to be delivered starting last quarter of 2016 in synchronisation with the readiness of terminal in North America.
RIL is also building a world-scale receiving and storage facility in India for liquefied ethane and pipeline to deliver ethane to the company's crackers. RIL will be upgrading its crackers to maximize cracking of Ethane, have maximum operational flexibility and capability to optimize feed stocks with complete control of supply chain. The project will significantly improve the long term competitiveness of the company's cracker portfolio through dedicated feedstock, enhanced margins, higher capacity and end to end integration, RIL said in a statement.
Bharat Forge turns ex-dividend today, 21 August 2014, for final dividend of Rs 2.50 per share for the year ended 31 March 2014.
Also Read
Bharti Airtel turns ex-dividend today, 21 August 2014, for total dividend of Rs 3.43 per share. Bharti Airtel had on 13 August 2014 declared an interim dividend of Rs 1.63 per share for the year ending 31 March 2015. Bharti Airtel had on 29 April 2014 declared dividend of Rs 1.80 per share for the year ended 31 March 2014
Dishman Pharmaceuticals and Chemicals turns ex-dividend today, 21 August 2014, for final dividend of Rs 1.20 per share for the year ended 31 March 2014.
Exide Industries turns ex-dividend today, 21 August 2014, for interim dividend of Rs 1.50 per share for the year ending 31 March 2015.
GNFC turns ex-dividend today, 21 August 2014, for dividend of Rs 3.50 per share for the year ended 31 March 2014.
Jubilant Life Sciences turns ex-dividend today, 21 August 2014, for dividend of Rs 3 per share for the year ended 31 March 2014.
MOIL turns ex-dividend today, 21 August 2014, for final dividend of Rs 3.50 per share for the year ended 31 March 2014.
Muthoot Finance turns ex-dividend today, 21 August 2014, for dividend of Rs 4.50 per share for the year ended 31 March 2014.
Neelamalai Agro Industries turns ex-dividend today, 21 August 2014, for dividend of Rs 40 per share for the year ended 31 March 2014.
Oberoi Realty turns ex-dividend today, 21 August 2014, for dividend of Rs 2 per share for the year ended 31 March 2014.
Tide Water Oil (India) turns ex-dividend today, 21 August 2014, for final dividend of Rs 200 per share for the year ended 31 March 2014
Aries Agro said that the company has commissioned on Wednesday, 20 August 2014 its first captive solar power generation unit with a capacity of 100 KW at its second largest manufacturing facility in Hyderabad. Set up at a project cost of Rs 80.51 lakh, this solar power generation will streamline the availability of power for manufacturing operations. The project was considered essential to reduce the dependence on fossil fuels and erratic grid power supply in the State of Telangana and is expected to also result in an appreciable savings in power and fuel expenses, Aries Agro said.
Jindal Saw after market hours on Wednesday, 20 August 2014 announced the acquisition of assets in US by its overseas step down subsidiary through bankruptcy proceedings. The company said that Jindal Tubular USA LLC, an entity incorporated in Delaware, USA and a step down subsidiary of the company (it is wholly owned by S.V Trading, Navis which in turn is a wholly owned subsidiary of the company), had entered into an asset purchase agreement on 16 June 2014 with PSL-North America LLC for the acquisition of identified assets and liabilities of PSL-North America LLC.
The acquisition was subject to the outcome of a voluntary petition for relief filed by PSL-North America LLC under Chapter 11 of Title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware including counter bids made by various other bidders and possible objections raised by lenders and creditors of PSL-North America LLC.
The United States Bankruptcy Court for the District of Delaware has passed an order on 15 August 2014 authorizing and approving the sale of substantially all of PSL- North America LLC's assets to Jindal Tubular USA LLC in accordance with the terms of the asset purchase agreement, free and clear of all liens, claims, encumbrances and other interests; approving the assumption and assignment of contracts; approving entering into ancillary agreements; and granting related relief. The acquisition is now expected to be completed on or prior to 31 August 2014, Jindal Saw said.
Huhtamaki PPL said that the company has allotted 1 crore equity shares at a price of Rs 134.08 per share aggregating to Rs 134.41 crore to Huhtavefa B. V., as approved by the shareholders of the company at extra-ordinary general meeting (EGM) of the company held on 6 August 2014.
Claris Lifesciences announced that it received the MHRA approval for its newly commissioned plant (plant 2). This will help in enhancing capacities to grow in the regulated markets, especially the European Union. The company's specialty injectables business saw a growth of 30% in the last quarter.
As on 30 June 2014, the company had approvals of 13 ANDAs in US, 14 molecules in the Europe and 11 molecules in other regulated markets (ORM), additionally, there are 28 ANDAs in the US, 8 molecules in Europe and 10 molecules in ORM, which are filed and awaiting approval. The company is currently functioning at high capacity utilization and is adding capacities in plant 2 to service future demands. To sustainably grow, attaining the required regulatory approvals is one of the key growth drivers; and the company has a large pipeline of products; which includes the under approval and the products currently under development, the company said in a statement.
The company's flagship plant (plant 1) is already approved by MHRA-UK. This is the first regulatory inspection and compliance approval conducted by MHRA-UK in line with the EU GMP regulations for Plant 2, this approval is for Terminally Sterilized products presented in glass ampoules manufactured in Line 1 of the plant 2.
The company has plans to install another line in this new plant (plant 2) which will be ready for commercial production by the end of this year. The existing line has capabilities to manufacture Aseptic Sterilized products as well, and the new line will have the capability to manufacture Lyophilized Products, Claris Lifesciences added.
Powered by Capital Market - Live News